Literature DB >> 15218035

An IAP-IAP complex inhibits apoptosis.

Takehiko Dohi1, Kazuya Okada, Fang Xia, Casey E Wilford, Temesgen Samuel, Kate Welsh, Hiroyouki Marusawa, Hua Zou, Robert Armstrong, Shu-ichi Matsuzawa, Guy S Salvesen, John C Reed, Dario C Altieri.   

Abstract

Regulators of apoptosis are thought to work in concert, but the molecular interactions of this process are not understood. Here, we show that in response to cell death stimulation, survivin, a member of the inhibitor of apoptosis (IAP) gene family, associates with another IAP protein, XIAP, via conserved baculovirus IAP repeats. Formation of a survivin-XIAP complex promotes increased XIAP stability against ubiquitination/proteasomal destruction and synergistic inhibition of apoptosis, which is abolished in XIAP(-/-) cells. Therefore, orchestration of an IAP-IAP complex regulates apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218035     DOI: 10.1074/jbc.C400236200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  150 in total

1.  Protection of CHO cells by transfer of survivin driven by ovarian-specific promoter OSP-2.

Authors:  Chun-Hua Tu; Wei-Peng Liu; Mei Dong; Li-Ping Cai; Ya-Qin Mo; Dong-Zi Yang
Journal:  Mol Biol Rep       Date:  2010-11-14       Impact factor: 2.316

Review 2.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Differential requirements for survivin in hematopoietic cell development.

Authors:  Sandeep Gurbuxani; Yanfei Xu; Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

4.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

5.  Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer.

Authors:  Samir F Zohny; Mohamed El-Shinawi
Journal:  Med Oncol       Date:  2010-10-27       Impact factor: 3.064

6.  Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Authors:  Takehiko Dohi; Elena Beltrami; Nathan R Wall; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Depletion of K-Ras promotes proteasome degradation of survivin.

Authors:  Awet Tecleab; Saïd M Sebti
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

9.  Fragment-based design of small molecule X-linked inhibitor of apoptosis protein inhibitors.

Authors:  Jui-Wen Huang; Ziming Zhang; Bainan Wu; Jason F Cellitti; Xiyun Zhang; Russell Dahl; Chung-Wai Shiau; Kate Welsh; Aras Emdadi; John L Stebbins; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

10.  PAK1 is a novel MEK-independent raf target controlling expression of the IAP survivin in M-CSF-mediated osteoclast survival.

Authors:  Elizabeth W Bradley; Ming M Ruan; Merry J Oursler
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.